2007
DOI: 10.1016/j.jaci.2006.11.639
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

Abstract: Background-Severe asthma causes the majority of asthma morbidity. Understanding mechanisms that contribute to the development of severe disease is important.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

57
782
7
34

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 840 publications
(898 citation statements)
references
References 41 publications
57
782
7
34
Order By: Relevance
“…50 Second, the claims data did not include the results of clinical data, such as peak expiratory flow or forced expiratory volume, to define disease severity and health status. 38,51 Therefore, we referred to previous studies to adopt the frequency of ambulatory visits for asthma, 25,26,30 hospitalization, 24 and ED visits 22,24,25 as a proxy for asthma severity, and we used CCI as a proxy indicator to present each patient's health status. 21,22,52 Third, we could not obtain patients' educational level or household income, and this may affect the measurement of COC and outcomes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…50 Second, the claims data did not include the results of clinical data, such as peak expiratory flow or forced expiratory volume, to define disease severity and health status. 38,51 Therefore, we referred to previous studies to adopt the frequency of ambulatory visits for asthma, 25,26,30 hospitalization, 24 and ED visits 22,24,25 as a proxy for asthma severity, and we used CCI as a proxy indicator to present each patient's health status. 21,22,52 Third, we could not obtain patients' educational level or household income, and this may affect the measurement of COC and outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…The total number of physician visits (N) and the number of visits to a given physician (n i ) include ambulatory claims (including clinic or hospital physician visits) in the principal diagnosis (ICD-9-CM code 493.xx). We calculated COCI 37 Patients' educational level or household income may affect health care outcomes 6,23,38 ; the NHI claims data set does not provide this information. Hence, insurance premiums were used as a proxy for socioeconomic status.…”
Section: Independent Variablementioning
confidence: 99%
“…The prevalence of comorbidities is particularly high in severe asthma, and these conditions can be quite detrimental to asthma control in such individuals [1,2,[190][191][192][193]. In the National Heart, Lung, and Blood Institute cohort, Moore et al found an increase in aspirin intolerance in severe compared with nonsevere asthma, as well as an increase in GERD (41 vs 12-16%), a history of sinusitis (54 vs 33-37%) and history of pneumonia (63 vs 35-36%) [190].…”
Section: Comorbidities and Severe Asthmamentioning
confidence: 99%
“…In the National Heart, Lung, and Blood Institute cohort, Moore et al found an increase in aspirin intolerance in severe compared with nonsevere asthma, as well as an increase in GERD (41 vs 12-16%), a history of sinusitis (54 vs 33-37%) and history of pneumonia (63 vs 35-36%) [190]. In another analysis of this Severe Asthma Research program cohort, Wenzel et al reported that severe asthma is associated with obesity, aspirin sensitivity and sinusitis in females, and inversely associated with atopy [191].…”
Section: Comorbidities and Severe Asthmamentioning
confidence: 99%
“…Тем не менее в ряде случаев не удается эффек-тивно контролировать симптомы бронхиальной астмы, несмотря на высокие дозы ингаляционных ГКС в сочета-нии с длительно действующими ␤-агонистами (long-acting ␤ 2 -agonists, LABA) или даже применение системных ГКС [20]. Среди взрослых пациентов примерно в 5-10% слу-чаев выявляется рефрактерная, плохо контролируемая астма, несмотря на максимальную ингаляционную тера-пию [21], и на нее приходится значительная доля потре-бления ресурсов здравоохранения [22].…”
Section: противовоспалительная терапия бронхиальной астмы глюкокортикunclassified